Toward the development of an injectable dosage form of propofol: Preparation and evaluation of propofol-sulfobutyl ether 7-β-cyclodextrin complex

Pharmaceutical Development and Technology

Volumn 9, Issue 3, 2004, Pages 265-275

  Babu, M K Manoj ^a   Godiwala, Tapan N ^b  

^a DSM Pharmaceutical Products   (Netherlands)

^b EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Inclusion complex; Modulated differential scanning calorimetry (MDSC); Nonclassical hydrophobic interaction; Propofol; Sulfobutylether 7 cyclodextrin (SBECD)

Indexed keywords

BETA CYCLODEXTRIN SULFOBUTYL ETHER; PROPOFOL;

ARTICLE; BINDING AFFINITY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DEVELOPMENT; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG SOLUBILITY; FREEZE DRYING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROPHOBICITY; MOISTURE; PRIORITY JOURNAL; THERMODYNAMICS;

ALGORITHMS; ANESTHETICS, INTRAVENOUS; BETA-CYCLODEXTRINS; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSAGE FORMS; DRUG STABILITY; FREEZE DRYING; INJECTIONS; PROPOFOL; REPRODUCIBILITY OF RESULTS; WATER;

EID: 4444281364     PISSN: 10837450     EISSN: None     Source Type: Journal    
DOI: 10.1081/PDT-200031428     Document Type: Article

References (28)

1. Sharma, A.; Straubinger, R.M. Novel taxol formulations: preparation and characterization of taxol-containing liposomes. Pharm. Res. 1994, 11, 889-896.
2. Tarr, B.D.; Sambandan, T.G.; Yalkowsky, S.H. A new parenteral emulsion for the administration of taxol. Pharm. Res. 1987, 4, 162-165.
3. Loftsson, T.; Brewster, M.E. Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J. Pharm. Sci. 1996, 85 (10), 1017-1025.
4. Rajewski, R.A.; Stella, V.J. Pharmaceutical applications of cyclodextrins. 2. Drug delivery. J. Pharm. Sci. 1996, 85 (11), 1142-1169.
5. Sharma, U.S.; Balasubramanian, S.V.; Straubinger, R.M. Pharmaceutical and physical properties of paclitaxel (Taxol) complexes with cyclodextrins. J. Pharm. Sci. 1995, 84 (10), 1223-1230.
6. Bhardwaj, R.; Dorr, R.T.; Blanchard, J. Approaches to reducing toxicity of parenteral anticancer drug formulations using cyclodextrins. PDA J. Pharm. Sci. Technol. 2000, 54 (3), 233-239.
7. Trapani, G.; Lopedota, A.; Franco, M.; Latrofa, A.; Liso, G. Effect of 2-hydroxypropyl-β-cyclodextrin on the aqueous solubility of the anesthetic agent propofol (2,6-diisopropylphenol). Int. J. Pharm. 1996, 139, 215-218.
8. Trapani, G.; Latrofa, A.; Massimo, F.; Lopedota, A.; Sanna, E.; Liso, G. Inclusion complexation of propofol with 2-hydroxypropyl-β-cyclodextrin. Physicochemical, nuclear magnetic resonance spectroscopic studies and anesthetic properties in rat. J. Pharm. Sci. 1998, 87 (4), 514-518.
9. Szente, L.; Szejtli, J. Highly soluble cyclodextrin derivatives: chemistry, properties and trends in development. Adv. Drug Deliv. Rev. 1999, 36, 17-28.
10. Ghorab, M.K.; Adeyeye, M.C. Enhancement of ibuprofen dissolution via wet granulation with β-cyclodextrin. Pharm. Dev. Technol. 2001, 6 (3), 305-314.
11. Jain, A.C.; Adeyeye, M.J. Hygroscopicity, phase solubility and dissolution of various substituted sulfobutylether β-cyclodextrins (SBE) and danazol-SBE inclusion complexes. Int. J. Pharm. 2001, 212, 177-186.
12. Dollo, G.; Le Coree, P.; Chollet, M.; Chevanne, F.; Bertault, M.; Burgot, J.L.; Le Verge, R. Improvement in solubility and dissolution rate of 1,2-dithiole-3-thiones upon complexation with β-cyclodextrin and its hydroxypropyl and sulfobutyl ether-7 derivatives. J. Pharm. Sci. 1999, 88 (9), 889-895.
13. Spamer, E.; Müller, D.G.; Wessels, P.L.; Venter, J.P. Characterization of the complexes of furosemide with 2-hydroxypropyl-β- cyclodextrin and sulfobutyl ether-7-b-cyclodextrin. Eur. J. Pharm. Sci. 2002, 16, 247-253.
14. Ficarra, R.; Ficarra, P.; Di Bella, M.R.; Raneri, D.; Tommasini, S.; Calabrò, M.L.; Villari, A.; Coppolino, S. Study of the inclusion complex of atenolol with β-cyclodextrins. J. Pharm. Biomed. Anal. 2000, 23, 231-236.
15. Nagase, Y.; Hirata, M.; Wada, K.; Arima, H.; Hirayama, F.; Irie, T.; Kikuchi, M.; Uekama, K. Improvement of some pharmaceutical properties of DY-9760e by sulfobutyl ether β-cyclodextrin. Int. J. Pharm. 2001, 229, 163-172.
16. Miyake, K.; Irie, T.; Arima, H.; Hirayama, F.; Uekama, K.; Hirano, M.; Okamoto, Y. Characterization of Itraconazole/2-hydroxypropyl-β-cyclodextrin inclusion complex in aqueous propylene glycol solution. Int. J. Pharm. 1999, 179, 237-245.
17. Giordano, F.; Novak, C.; Moyano, J.R. Thermal analysis of cyclodextrins and their inclusion compounds. Thermochim. Acta 2001, 380, 123-151.
18. Baker, M.T.; Gregerson, M.S.; Martin, S.M.; Buettner, G.R. Free radical and drug oxidation products in an intensive care unit sedative: propofol with sulfite. Crit. Care. Med. 2003, 31 (3), 981-983.
19. Higuchi, T.; Connors, K.A. Phase solubility techniques. Adv. Anal. Chem. Instr. 1965, 4, 117-212.
20. Menard, F.A.; Dedhiya, M.G.; Rhodes, C.T. Physico-chemical aspects of complexation of some drugs with cyclodextrins. Drug Dev. Ind. Pharm. 1990, 16 (1), 91-113.
21. Rekharsky, M.V.; Goldeberg, R.N.; Schwarz, F.P.; Tewari, Y.B.; Ross, P.D.; Yamashoji, Y.; Inoue, Y. Thermodynamic and nuclear magnetic resonance study of the interactions of α- and β- cyclodextrin with model substances: phenethyl amine, ephedrines and related substances. J. Am. Chem. Soc. 1995, 117 (34), 8830-8840.
22. Rekharsky, M.V.; Inoue, Y. Complexation themodynamics of cyclodextrins. Chem. Rev. 1998, 98 (5), 1875-1917.
23. Zia, V.; Rajewski, R.A.; Stella, V.J. Thermodynamics of binding of neutral molecules to sulfobutyl ether b-cyclodextrins (SBE-β-CDs): the effect of total degree of substitution. Pharm. Res. 2000, 17 (8), 936-941.
24. Granero, G.; Longhi, M. Thermal analysis and spectroscopic characterization of interactions between a naphthoquinone derivative with HP-β-CD or PVP. Pharm. Dev. Technol. 2002, 7 (3), 381-390.
25. Bettinetti, G.P.; Sorrenti, M.; Rossi, S.; Ferrari, F.; Mura, P.; Faucci, M.T. Assessment of solid-state interactions of naproxen with amorphous cyclodextrin derivatives by DSC. J. Pharm. Biomed. Anal. 2002, 30, 1173-1179.
26. Clas, S.-D.; Dalton, C.R.; Hancock, B.C. Differential scanning calorimetry: applications in drug development. Pharm. Sci. Technol. Today 1999, 2 (8), 311-320.
27. Coleman, N.J.; Craig, D.Q.M. Modulated temperature differential scanning calorimetry: a novel approach to pharmaceutical thermal analysis. Int. J. Pharm. 1996, 135, 13-29.
28. Rabel, S.R.; Jona, J.A.; Maurin, M.B. Applications of modulated differential calorimetry in preformulation studies. J. Pharm. Biomed. Anal. 1999, 21, 339-345.